Nov 29 (Reuters) - Genetic Technologies Ltd GTG.AX
* Genetic Technologies Limited and the University of Melbourne enter into exclusive worldwide license agreement to develop colorectal cancer risk assessment test Source text for Eikon: ID:nMKWnSxSba Further company coverage: GTG.AX